Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4915344> ?p ?o }
Showing triples 1 to 21 of
21
with 100 triples per page.
- Q4915344 subject Q7112257.
- Q4915344 subject Q7483641.
- Q4915344 subject Q8301171.
- Q4915344 subject Q8691986.
- Q4915344 abstract "Biotecnol is an immune-oncology company focusing on the development of multifunctional antibodies, targeting highly heterogeneous oncological situations. Using its technologies, Biotecnol is developing oncological treatments for high unmet-needs such as triple negative breast cancer, malignant mesothelioma and some other highly-aggressive cancer mutated subtypes".
- Q4915344 wikiPageExternalLink www.biotecnol.com.
- Q4915344 wikiPageWikiLink Q1269766.
- Q4915344 wikiPageWikiLink Q2388241.
- Q4915344 wikiPageWikiLink Q245247.
- Q4915344 wikiPageWikiLink Q25419.
- Q4915344 wikiPageWikiLink Q3060689.
- Q4915344 wikiPageWikiLink Q49108.
- Q4915344 wikiPageWikiLink Q597.
- Q4915344 wikiPageWikiLink Q7112257.
- Q4915344 wikiPageWikiLink Q7483641.
- Q4915344 wikiPageWikiLink Q783794.
- Q4915344 wikiPageWikiLink Q8301171.
- Q4915344 wikiPageWikiLink Q8691986.
- Q4915344 wikiPageWikiLink Q926700.
- Q4915344 comment "Biotecnol is an immune-oncology company focusing on the development of multifunctional antibodies, targeting highly heterogeneous oncological situations. Using its technologies, Biotecnol is developing oncological treatments for high unmet-needs such as triple negative breast cancer, malignant mesothelioma and some other highly-aggressive cancer mutated subtypes".
- Q4915344 label "Biotecnol".